Objective To analyze the functional dyspepsia patients taking combined therapy on symptoms and gastric accommodation effect. Methods 80 cases of functional dyspepsia were randomly divided into study group and control group, each of 40 cases. The control group took mosapride, while the study group took mosapride combined with compound azintamide treatment, observed and recorded the two groups of patients with clinical effect, and the integral of symptom, gastric accommodation, and comparative analysis. Results The study group total effective rate was significantly better than the control group. The difference was staistically significant (P<0.05);after treatment of symptom integral group decreased more significantly than the control group after treatment. The difference was staistically significant (P<0.05);maximum water quantity research group increased more significantly than the control group. The difference was staistically significant (P<0.05). Conclusion In patients with functional dyspepsia take combination therapy for treatment can significantly improve symptoms, while improving gastric receptive level, curative effect, is worth learning from.%目的：分析功能性消化不良患者采取联合疗法对症状及胃容受性的影响效果。方法80例功能性消化不良患者随机均分为研究组与对照组，各40例。对照组采取莫沙必利治疗，而研究组采取莫沙必利联合复方阿嗪米特治疗，观察记录两组患者的疗效，以及治疗前后症状积分、胃容受性情况，并对比分析。结果研究组治疗总有效率明显优于对照组，差异有统计学意义（P＜0.05）；治疗后症状积分研究组下降较对照组更明显（P＜0.05）；治疗后最大饮水量研究组升高较对照组更明显，差异有统计学意义（P＜0.05）。结论功能性消化不良患者采取联合疗法治疗可以明显改善症状，同时提高胃容受性水平，疗效确切，值得借鉴。
展开▼
